Lisicki Robert
Cadrenal Therapeutics, Inc. Common Stock · Director
Lisicki Robert is listed in filings as Director at Cadrenal Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through Jan 24, 2025, including 1 public disclosure. Recent filings connect the profile to Cadrenal Therapeutics, Inc. Common Stock (CVKD). The current snapshot covers public activity from Jan 24, 2025. Reported amounts are shown as $395.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||